Patient Guide: Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 30 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05389215
Status: 🟢 Enrolling Now
Condition: Idiopathic Pulmonary Fibrosis
Phase: PHASE2

Where You Can Participate

This study is available at 30 locations across the country.

Top locations include:
  • • Mesa, Arizona
  • • Phoenix, Arizona
  • • San Francisco, California
  • • And 27 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF - Join Clinical Trial NCTNCT05389215

How to Join This Clinical Trial - NCTNCT05389215

Learn how to participate in this PHASE2 trial studying an investigational therapy for Idiopathic Pulmonary Fibrosis. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Idiopathic Pulmonary Fibrosis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Idiopathic Pulmonary Fibrosis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05389215 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 30 locations. Find a study site near you:

Clinical Research Site

Mesa, Arizona 85206-1346 - United States

Status: RECRUITING

Clinical Research Site

Phoenix, Arizona 85013 - United States

Status: RECRUITING

Clinical Research Site

San Francisco, California 94143 - United States

Status: RECRUITING

Clinical Research Site

Maywood, Illinois 60153 - United States

Status: RECRUITING

Clinical Research Site

Kansas City, Kansas 66160 - United States

Status: RECRUITING

Clinical Research Site

Boston, Massachusetts 02111 - United States

Status: RECRUITING

Clinical Research Site

Boston, Massachusetts 02215 - United States

Status: RECRUITING

Clinical Research Site

Michigan Center, Michigan 48109 - United States

Status: RECRUITING

Clinical Research Site

Chesterfield, Missouri 63017 - United States

Status: RECRUITING

Clinical Research Site

Durham, North Carolina 27705 - United States

Status: RECRUITING

And 20 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Idiopathic Pulmonary Fibrosis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships